Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties

Clinical Microbiology and Infection

Volumn 9, Issue 4, 2003, Pages 280-288

  Maugein, Jeanne ^a   Guillemot, D ^b   Dupont, M J ^c   Fosse, T ^d   Laurans, G ^e   Roussel Delvallez, M ^f   Thierry, J ^h   Vergnaud, M ^h   Weber, M ^h   Poirier, B ^g  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g SmithKline Beecham   (France)

^h NONE

Author keywords

Bacteremia; Epidemilogy; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; PENICILLIN G;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FATALITY; FEMALE; FRANCE; GENDER; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEROTYPE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038748126     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00520.x     Document Type: Article

References (27)

1. Chomarat M, Laurans G, Chanal C et al. Evolution of resistance of clinical streptococcus pneumoniae and analysis of serotypes of PRP in France in 1999 [abstract 1794]. In: Program and abstracts of the 40th International Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington, DC: American Society for Microbiology, 2000: 114.
2. Acar J, Carret G, Cavalo JD et al. Communiqué 1998 du comité de l'antibiogramme de la Société Française de Microbiologie. Path Biol 1998; 46: I-XVI.
3. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 2000.
4. Roussel-Delvallez M, Demachy MC, Vernet-Garnier V et al. Résistance du pneumocoque aux antibiotiques en France en 1997. BEA 1998; 2: 183-6.
5. Bedos JP, Vallée E, Moine P, Geslin P, Chastang C. Pneumonies à S. pneumoniae de sensibilité diminuée à la pénicilline: données épidémiologiques, facteurs de risque et impact thérapeutique. Med Mal Infect 1995; 25: 1-8.
6. Marchese A, Debbia E, Pesce A, Schito GC. Comparative activities of amoxicillin and 10 other oral drugs against penicillin-susceptible and resistant Streptococcus pneumoniae strains recently isolated in Italy. Clin Microbiol Infect 1998; 4: 170-3.
7. Vanhoof R. Comparative in vitro activities of amoxicillin and penicillin against Streptococcus pneumoniae isolates. J Antimicrob Chemother 1998; 42: 397-8.
8. Corrihons V, Abinars A, Arminaud du Chatelet A et al. Enquête épidémiologique régionale sur la résistance aux antibiotiques de Streptococcus pneumoniae; résultats de l'Observatoire Pneumocoque région Aquitaine. Med Mal Infect 1997; 27(spécial): 16-23.
9. Kaplan SL, Masson EO, Barson WJ et al. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J 2001; 20: 392-6.
10. McKensie H, Reid N, Dijkhuizen RS. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia. J Med Microbiol 2000; 49: 361-6.
11. Hausdorff W, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use. Clin Infect Dis 2000; 30: 122-40.
12. Geslin P. Rapport d'activité année 1997. Paris: Centre National de Référence du Pneumocoque, 1997.
13. Kaplan S, Mason EO, Barson WJ et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998; 102: 538-45.
14. Metlay JP, Hofmann J, Cetron MS et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteriemic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-8.
15. Nava JM, Bella F, Garau J et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19: 884-90.
16. Garcia-Leoni ME, Cercenado E, Rodeno P, Bernaldo de Quiros JCL, Martinez-Hernandez D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14: 427-35.
17. Pallares R, Gudiol F, Linares J et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumoniae caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317: 18-22.
18. Deeks SL, Palacio R, Ruvinsky R et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics 1999; 103: 409-13.
19. Haylund LA, Istre GR, Pickett DA, Welch DF, Fine DP, the Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993; 168: 1532-6.
20. Ekdahl K, Martensson A, Kamme C. Bacteraemic pneumococcal infections in southern Sweden 1981-96: trends in incidence, mortality, age-distribution, serogroups and penicillin resistance. Scand J Infect Dis 1998; 30: 257-62.
21. Pallares R, Linares J, Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80.
22. Choi EH, Lee HJ. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 1998; 26: 1346-54.
23. Feikin DR, Schuchat A, Kolczak M et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90: 223-9.
24. Torres JM, Cardenas O, Vasquez A, Schlossberg D. Streptococcus pneumoniae bacteremia in a community hospital. Chest 1998; 113: 387-90.
25. Winston LG, Perlman JL, Rose DA, Gerberding JL. Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco general hospital. Clin Infect Dis 1999; 29: 580-5.
26. Mirzanejad Y, Roman S, Talbot J, Nicolle L, the pneumococcal bacteremia study group. Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Chest 1994; 19: 884-90.
27. Teira R, Munoz J, Zubero Z, Rojo P, Cisterna R, Santamaria JM. Epidemiologic characteristics of pneumococcal bacteremia in the era of AIDS. Enferm Infect Microbiol Clin 1992; 10: 138-42.